How California, now an epicenter for bird flu in dairy cattle, is monitoring the virus
California now has more bird flu-infected cattle herds than any other U.S. state.
Related Articles
FDA: Veozah, First Hormone-Free Hot Flash Drug, Issued Black Box Warning
WEDNESDAY, Dec. 18, 2024 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has issued its most serious warning — a black-box warning —…
USPSTF Recommends Against Vitamin D Supplementation for Fracture, Fall Prevention
TUESDAY, Dec. 17, 2024 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends against vitamin D supplementation, with or without calciu
Florida unveils new artificial intelligence-driven emergency messaging system
The BEACON system converts important safety information from text to voice and delivers it over the radio within minutes of being issued.
Colon Cancer Rates Are Up Among the Young Worldwide
MONDAY, Dec. 16, 2024 (HealthDay News) — More young people around the world are falling prey to colon cancer, a new study shows.Colon cancer rates…
New CMS model could slash provider earnings: researchers
An Institute for Accountable Care report says hospitals could lose an average of $500 per episode of covered services — but the forecast varies widely.
ACP Gastroenterology Monthly
ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
Best of JAMA Network 2024
Revisit the listened to audio and podcasts at JAMA and the JAMA Network in 2024.
Acupuncture vs Sham Acupuncture for Chronic Sciatica From Herniated Disk
This multicenter randomized clinical trial investigates the efficacy and safety of acupuncture compared with sham acupuncture in patients with chronic sciatica from herniated disk.
Impact of US Tobacco 21 Policies on Potential Mortality Reductions by State
Research shows that Tobacco 21 (T21) policies with a minimum legal age to purchase tobacco products of 21 years reduce youth smoking, yet their potential…
CagriSema Achieves 22.7% Weight Loss in Phase 3 REDEFINE 1 Trial
CagriSema, a fixed dose of cagrilintide 2.4 mg and semaglutide 2.4 mg, achieved statistically significant weight loss after 68 weeks versus placebo.
